VEGFA and psoriasis: In our present study, we investigated the therapeutic effects of IL‐35 recombinant protein in DSS‐induced acute colitis mouse model, K14‐VEGF transgenic psoriasis mouse model and IMQ‐induced psoriasis mouse model.